By exemplifying how patient engagement can shorten clinical research and drug development timelines (and costs), rare disease and special population patient advocacy groups have changed the models and concepts underlying therapeutic development for even the most common diseases. DIA elevates these unique perspectives and contributions throughout the global healthcare ecosystem via our Patient Fellowships and similar programs.
Learning
DIA Digital Learning Catalog
DIA Learning programs provide unique, realistic opportunities for professionals to learn best practices in their fields with Internet-based courseware, conveniently accessible anytime, anywhere.
Patient Engagement Community
DIA PEC is a learning community for fostering collaboration between those who represent the patient and those who work to integrate patient needs into the process of medicines development, approval and commercialization.